Holen Sie sich die Stockscreener-App
17.96
0.22%
-0.04
Handel nachbörslich:
17.96
Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten
Elanco CEO Jeff Simmons: Innovation and Sustainability Drive Long-Term Growth - ACCESS Newswire
Can Elanco Animal Health Incorporated outperform under higher oil pricesEarnings Beat & Reliable Price Action Trade Plans - sundaytimes.kr
Elanco Animal Health's (NYSE:ELAN) Solid Earnings May Rest On Weak Foundations - uk.finance.yahoo.com
Leerink Partnrs Issues Negative Outlook for ELAN Earnings - MarketBeat
Elanco (ELAN) Q2 Revenue Jumps 5% - AOL.com
Elanco Animal Health stock hits 52-week high at 17.85 USD - Investing.com Canada
Piper Sandler Issues Positive Forecast for Elanco Animal Health (NYSE:ELAN) Stock Price - MarketBeat
5 Insightful Analyst Questions From Elanco’s Q2 Earnings Call - FinancialContent
Nuveen LLC Makes New Investment in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Animal Health (NYSE:ELAN) Stock Price Expected to Rise, UBS Group Analyst Says - MarketBeat
Elanco spearheads Nutrition Secure Indianapolis initiative to provide food aid - Inside INdiana Business
Dogs Vaccines Market Exclusive Report with Detailed Study - openPR.com
Cary Street Partners Financial LLC Buys New Shares in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Animal Health Posts Robust Q2 Earnings, Exceeds Guidance with Strong Organic Growth and Innovation - AInvest
Elanco’s Q2 2025 Return to Profitability Signals Growth - Zenopa
Leerink Partners Keeps Buy Rating on Elanco Animal Health with $20 Price Target - AInvest
ELAN Q2 Deep Dive: Innovation and Execution Drive Raised Full-Year Outlook - FinancialContent
Elanco Animal Health (NYSE:ELAN) Posts Earnings Results, Beats Expectations By $0.06 EPS - MarketBeat
Elanco Animal Health (NYSE:ELAN) Releases Q3 2025 Earnings Guidance - MarketBeat
Elanco Animal Health: Piper Sandler raises PT to $18 from $12, maintains Neutral rating. - AInvest
Elanco Animal Health (NYSE:ELAN) Updates FY 2025 Earnings Guidance - MarketBeat
Price Consolidation Hints at Upcoming Move in Elanco Animal Health IncorporatedReversal Alert Based on RSI Indicator Confirmed - metal.it
Arkadios Wealth Advisors Makes New Investment in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco (ELAN) Jumps 19.7% to Record High on Earnings Boost - MSN
Elanco Animal Health Surges 9% on Q2 Results and Optimistic Full-Year Forecast - AInvest
Elanco Animal Health: Analyst Sentiment Analysis and 12-Month Price Targets - AInvest
Elanco Animal Health Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Elanco Animal Health Incorporated (NYSE:ELAN) Q2 2025 Earnings Call Transcript - Insider Monkey
Analysts Offer Insights on Healthcare Companies: GoodRx Holdings (GDRX) and Elanco Animal Health (ELAN) - The Globe and Mail
Elanco Animal Health (ELAN) Gets a Buy from Bank of America Securities - The Globe and Mail
Elanco Animal Health Reports Strong Q2 2025 Results - The Globe and Mail
Chart based analysis of Elanco Animal Health Incorporated trendsTrend Confirmation Scanner with Entry Focus - Newser
ICYMI: Elanco Shares Jump After 2Q Beat-and-Raise Results - iHeart
Elanco Puppy Virus Treatment Expanded With USDA Approval - InkFreeNews.com
UBS Raises PT to $19 for Elanco Animal Health Amid Bullish Outlook - AInvest
A Quick Look at Today's Ratings for Elanco Animal Health(ELAN.US), With a Forecast Between $15 to $21 - 富途牛牛
An Intrinsic Calculation For Elanco Animal Health Incorporated (NYSE:ELAN) Suggests It's 36% Undervalued - Yahoo Finance
Elanco Animal Health shares fall 1.40% premarket after beating Q2 revenue estimates and raising FY guidance. - AInvest
What institutional flow reveals about Elanco Animal Health IncorporatedStrong Buy Signal Summary with Entry Zone - Newser
Elanco Animal Health Inc (ELAN) Q2 2025 Earnings Call Highlights: Strong Pet Health Growth and ... By GuruFocus - Investing.com Canada
Elanco Animal Health 2025 Q2 Earnings Strong Performance as Net Income Surges 122% - AInvest
Elanco Raises 2025 Innovation Revenue Outlook to $720M-$800M, Signals Margin Expansion Through New Launches. - AInvest
10 Hot Stocks Making Winning Look Easy - Insider Monkey
Elanco's Q2 2025 Earnings Call: Unraveling Key Contradictions in FX Impact, Innovation Growth, and Margin Dynamics - AInvest
Elanco Animal Health Q2 2025: Innovation-Driven Growth and Accelerated Deleveraging Justify a Buy Rating - AInvest
Elanco Animal Health shares fall 1.55% after-hours despite beating Q2 revenue estimates and raising FY guidance. - AInvest
Elanco's Q2 Revenue Exceeds Expectations, Raises Full-Year Guidance - AInvest
Elanco bolsters parvovirus treatment with new approval - Inside INdiana Business
Elanco (NYSE:ELAN) Delivers Impressive Q2, Stock Jumps 15.4% - Yahoo Finance
Elanco Animal Health Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: Elanco Animal Health beats Q2 2025 expectations By Investing.com - Investing.com Canada
Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Beat Estimates - MSN
Why Is Elanco Animal Health Stock Soaring Thursday?Elanco Animal Health (NYSE:ELAN) - Benzinga
Elanco Animal Health Surges 16.4% to 52-Week High: What’s Fueling This Explosive Move? - AInvest
Elanco Animal Health stock hits 52-week high at $15.79 By Investing.com - Investing.com Canada
Elanco Animal Health (ELAN) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
Elanco Animal Health Inc SEC 10-Q Report - TradingView
Elanco stock spikes after Q2 beat, guidance raise (ELAN:NYSE) - Seeking Alpha
Elanco Animal Health’s Stock Faces Unusual Movement - TipRanks
Elanco (ELAN) Q2 Revenue Jumps 5% - The Motley Fool
Elanco Animal Health earnings beat by $0.06, revenue topped estimates - Investing.com Canada
Elanco Q2 2025 slides: 8% organic growth drives raised guidance despite headwinds - Investing.com Canada
Elanco Animal Health beats Q2 revenue estimates, raises FY guidance - MarketScreener
0.78%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):